MetaVia Inc.
Current role
MTVA
Andrew I. Koven
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew I. Koven
Andrew I. Koven was last confirmed as Board Member at KALA BIO, Inc. (KALA) in a filing dated December 30, 2025. Earlier roles on record: Board Member at KALA BIO, Inc. (KALA) until December 19, 2025. KALA BIO, Inc. reported in an 8-K filed February 2, 2026 that Andrew I. Koven resigned as Class I director, effective December 19, 2025. KALA BIO, Inc. reported in an 8-K filed December 29, 2025 that Andrew I. Koven resigned as director.
“on December 19, 2025, each of (i) Marjan Farid, M.D. and Andrew I. Koven, who were Class I directors of the Company, (ii) Mark Iwicki and Todd Bazemore were Class II directors of the Company, and (iii) C. Daniel Meyers and Howard B. Rosen, who were Class III directors of the Company (collectively, the "Resigning Directors"), tendered their resignations as directors of the Company, effective immediately following the Annual Meeting and upon approval of the Issuance Proposal and the Share Increase Proposal”
“each of Marjan Farid, M.D., Andrew I. Koven, C. Daniel Myers, Todd Bazmore, Mark Iwicki, and Howard B. Rosen tendered on December 19, 2025 a conditional resignation from their positions as director effective immediately after the Company's 2025 Annual Meeting if stockholder approval is obtained at such 2025 Annual Meeting”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
MetaVia Inc. (MTVA)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2025-12-30
Last confirmed by a filing; no departure on record
-
Start not stated–2025-12-19
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at MetaVia Inc.
Other people whose current roles at this company are on record from its filings.
- Ben Gil Price CEO
- Hyung Heon Kim CEO, CFO, Chief Accounting Officer, Board Member
- Joseph Hooker CEO, CFO, Chief Accounting Officer
- Richard Kang CEO
- Douglas J. Swirsky Chairman, Board Member
- Marshall H. Woodworth CFO, Chief Accounting Officer
- Marshall Woodworth CFO
- Akash Bakshi COO
- Andrew Koven Board Member
- D. Gordon Strickland Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.